Bentham Science Publishers

Bentham Science Publishers, a major STM journal publisher of 89 titles in 2008, answers the information needs of the pharmaceutical, bio and medical research community. Leading journals include Current Cancer Drug Targets (Impact Factor 5.385) and Current Medicinal Chemistry (Impact Factor 4.944).

• FREE online journals & information: www.bentham.org
• FREE Online institutional trials, Subscribe, Consortia, global licenses: subscriptions@bentham.org

BioProcess International provides the biotechnology industry with peer-reviewed editorial necessary to successfully drive products through the biopharmaceutical, biovaccine and biodiagnostic development process. Our BPA audited circulation consists of 30,022 mid-to-upper managers working in all phases of the biotherapeutic development in the US, Europe and Canada.

For more information visit: www.bioprocessintl.com

Biotechniques

“You can’t do science without BioTechniques”
Matthew Winkler, Founder of Ambion/CEO of Asuragen

Research is the core of the life sciences community. Researchers need access to novel methods and innovative techniques which are critical to the advancement of their valuable work. For this reason, researchers need to have direct access to BioTechniques in print and online. 
 
Every issue of BioTechniques is read and used. With an editorial board of innovators, academic scientists and industry leaders, among them Nobel Laureates, all of whom have a finger on the pulse of science – you can be sure that our content is original, cutting-edge and intellectually valued.
 
If research is the lifeblood of science than BioTechniques is the heart.

www.biotechniques.com/

The Expert Opinion series of journals provide systematic and authoritative analysis to support every stage in the pharmaceutical pipeline.

Our expertly crafted review articles enable the R&D community to access and track the key advances that lead to the creation of new drugs.

The distinctive “Expert Opinion” section within each review provides a personal commentary from the author on the most effective and promising strategies: an invaluable resource for decision-makers in the field.

For more information or to request a trial visit www.expertopin.com, email expertopin@informa.com or call +44 (0)20 7017 6941 today!

Genetic Engineering & Biotechnology News (GEN) is the most authoritative and widely read biotechnology news publication in the world.Published 21times a year,GEN's unique news and technology content focus includes the entire bioproduct life cycle from early-stage R&Dto applied research and bioprocess through to commercialization.GEN is the only publication that provides the full range ofthe biotechnology market coverage in areas such as omics,drugand biomarker discovery,bioprocessing,clinical research,molecular diagnostics,and biobusiness.For a free subscription,go to http: www.genennews.com/subscriptions.aspx

The Hungarian Biotechnology Association (HBA) was established by Hungary’s leading life science companies in 2003. The main objective of the organization is to create an alliance that unites the voice and interests of companies, researchers, academic institutions and related organizations to provide them with shared services, advocacy, and to help them find success and opportunities in the field of life sciences. HBA regards the representation of Hungary’s biotechnology sector as its most important activity. Furthermore, the Association’s goals include winning governmental support for the biotechnology sector – in order to reach this, the organization prepares documents and carries out harmonized lobbying activities. HBA is also a member of various international biotechnological organizations such as EuropaBio (http://www.europabio.org/), the Biotechnology Industry Organization (www.bio.org) and the European Federation of Biotechnology (www.efbweb.org).

Contacts:
Address: H-6726 Szeged, Kozep fasor 52.
Tel.:+36 62 312 559
Fax:+ 36 62 420 617
e-mail: info@hungarianbiotech.org
website: www.hungarianbiotech.org

Report Buyer is the intelligent way to buy market research online. Browse and choose from a current and comprehensive range of specialised intelligence from leading publishers covering most industry and market sectors.
Report Buyer now has over 85,000 reports covering most industry sectors, visit our website at www.reportbuyer.com

Companies in the pharma sector are scrutinising their business models and taking drastic action to survive the economic downturn. Sign up for a FREE 5-day trial today and let Scrip's team of journalists and analysts provide you with the pharmaceutical business intelligence you need to build a robust business strategy and stay ahead. Start your free trial today at http://www.scripnews.com/freeTrial

Scrip comprises Scrip World Pharmaceutical News, a weekly print newsletter and Scripnews.com, an online global pharma news and analysis service. Scrip’s authoritative, unbiased coverage includes policy & regulation, business, R&D, generics, drug delivery and clinical trials. www.scripnews.com – E: scripnews@informa.com

Select Science

SelectScience is an independent application and product information resource for laboratory scientists! Featuring the latest news, application notes, jobs, conferences and user's views on products, visitors can also rate the products they use in the lab. Visit www.selectscience.net now, to see why we are “the scientist’s choice”!

Swiss Biotech Association

Swiss Biotech Association (SBA) was founded in March 1998. Today more than 160 companies represent this growing association. SBA is the industry association of small and medium-sized enterprises active in all areas of biotechnology but also a very good networking platform for the multinational companies active in the sector. The membership is open to companies of various size concerned with different aspects of modern biotechnology such as R&D, production, marketing and sales, finance, services and consulting.

Activities of member companies span different sectors of biotechnology including pharmaceuticals, diagnostics, agriculture, fod, environmental biotechnology, and specialty chemicals. The SBA is also managing the national Cluster for Biotechnology where the Swiss Life Science regions the finance market (SWX) and the industry work together to promote Switzerland as a key Biotech country.